46,XX gonadal dysgenesis

46,XX gonadal dysgenesis, also known as XX gonadal dysgenesis or pure gonadal dysgenesis 46,XX type, is a rare disorder of sex development in which individuals have a normal female chromosomal complement (46,XX) but their ovaries fail to develop properly, being replaced by nonfunctional fibrous tissue known as streak gonads. This condition primarily affects the reproductive and endocrine systems. Because the streak gonads cannot produce adequate sex hormones, affected individuals typically present with primary amenorrhea (absence of menstruation), delayed or absent puberty, lack of secondary sexual characteristics such as breast development and pubic hair, and infertility. External genitalia are typically female, and internal Müllerian structures (uterus and fallopian tubes) are usually present but may be underdeveloped. Elevated gonadotropin levels (hypergonadotropic hypogonadism) are a hallmark laboratory finding. The condition can be caused by mutations in several genes, including FSHR, BMP15, NR5A1 (SF1), and others, though in many cases the underlying genetic cause remains unidentified. Both autosomal recessive and autosomal dominant inheritance patterns have been described depending on the specific gene involved. Some cases appear to be sporadic. Treatment centers on hormone replacement therapy (HRT) with estrogen and progesterone to induce puberty, develop secondary sexual characteristics, maintain bone health, and support overall well-being. Fertility options are limited, though assisted reproductive technologies using donor oocytes with the patient's own uterus may be possible in some cases. Psychological support is also an important component of care. Regular monitoring of bone density and cardiovascular health is recommended due to the long-term effects of estrogen deficiency.

Common questions about 46,XX gonadal dysgenesis